In most cases, AhR activation results in the alteration of the tumor-immune cell interactions, with suppression of anti-tumor functions and induction of tumor-permissive or tumor-promoting immune landscapes, as AhR has been shown to regulate the differentiation of multiple cell types in both the innate and the adaptive immune response compartments. The gene discussed is AHR; the disease is neoplasm.